 |
|
Genetic cause of innate resistance to HIV/AIDS
July 17, 2008Some people may be naturally resistant to infection with HIV, the virus that causes AIDS. The results of a study conducted by Dr. Nicole Bernard of the Research Institute of the McGill University Health Centre (MUHC) bring us closer to a genetic explanation. Her study findings were published on July 16 in the journal AIDS.
The simultaneous expression of certain versions of two specific genes called KIR3DL1 and HLA-B*57 is thought to be at the root of some cases of this innate resistance to HIV infection. Depending on which versions of these two genes the patient has, he or she will resist HIV infection or develop AIDS at a slower rate.
These results were obtained by comparing the genetic profiles of people undergoing primary HIV infection ( in their first year of infection) to those repeatedly exposed to HIV but non-infected. The group of exposed but non-infected patients came from a cohort studied by Dr. Julie Bruneau of the Centre hospitalier de l'Université de Montréal. The cohort of primary HIV infected patients is studied by Dr. Jean-Pierre Routy, from the MUHC. Analyses show that the "good" versions of both genes were present in 12.2% of exposed but non-infected subjects versus only 2.7% in patients in primary HIV infection.
As of yet, no study has clearly described the mechanism of this protection. The KIR3DL1 gene codes for a receptor on the surface of the immune system's natural killer (NK) cells, which when activated destroy infected cells in the body. The HLA-B*57 gene codes for a protein normally found on the surface of all body cells that binds the KIR3DL1 and dampens NK cell activity. The most likely hypothesis is that HIV prevents the HLA-B*57-encoded protein from being expressed on the surface of the infected cells, making it unavailable to bind KIR3DL1. As a consequence, the NK cells retain their activity and destroy the virus-infected cells.
As this mechanism can occur very soon after the virus has started to infect the body cells, people carrying those versions of the 2 genes may be able to destroy more efficiently the infected cells following exposure to HIV, thus lowering their chances of developing AIDS.
"More research is needed to determine the exact mechanism behind the protection we have observed, but these findings have revealed a promising avenue," according to Dr. Bernard.
This study opens the way for new ideas in the fight against HIV infection. "In the future, our findings could be used to somehow 'boost' the innate immune system and thus fight the virus as soon as it enters the body," said Dr. Bernard.
McGill University Health Centre
As of yet, no study has clearly described the mechanism of this protection. The KIR3DL1 gene codes for a receptor on the surface of the immune system's natural killer (NK) cells, which when activated destroy infected cells in the body. The HLA-B*57 gene codes for a protein normally found on the surface of all body cells that binds the KIR3DL1 and dampens NK cell activity. The most likely hypothesis is that HIV prevents the HLA-B*57-encoded protein from being expressed on the surface of the infected cells, making it unavailable to bind KIR3DL1. As a consequence, the NK cells retain their activity and destroy the virus-infected cells.
As this mechanism can occur very soon after the virus has started to infect the body cells, people carrying those versions of the 2 genes may be able to destroy more efficiently the infected cells following exposure to HIV, thus lowering their chances of developing AIDS.
"More research is needed to determine the exact mechanism behind the protection we have observed, but these findings have revealed a promising avenue," according to Dr. Bernard.
This study opens the way for new ideas in the fight against HIV infection. "In the future, our findings could be used to somehow 'boost' the innate immune system and thus fight the virus as soon as it enters the body," said Dr. Bernard.
McGill University Health Centre
Hiv Infection Current Events and Hiv Infection News RSSHIV drug maraviroc effective for drug-resistant patients
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death.
Scientists unmask key HIV protein, open door for more powerful AIDS drugs
University of Michigan scientists have provided the most detailed picture yet of a key HIV accessory protein that foils the body's normal immune response.
New UNC laboratory to help track and control tropical diseases
The University of North Carolina at Chapel Hill School of Public Health has established a new Gillings Innovation Lab to track and map tropical infectious diseases such as malaria, using state-of-the-art molecular and demographic methods.
Study examines cost-effectiveness of HIV monitoring strategy in countries with limited resources
In a computer-based model evaluating the benefits and costs of three types of HIV disease monitoring strategies, early initiation of antiretroviral therapy and monitoring using the CD4 count, a measure of immune system function, instead of based on symptoms appear to provide health benefits in low- and middle-income countries.
Why some primates, but not humans, can live with immunodeficiency viruses and not progress to AIDS
Key differences in immune system signaling and the production of specific immune regulatory molecules may explain why some primates are able to live with an immunodeficiency virus infection without progressing to AIDS-like illness, unlike other primate species, including rhesus macaques and humans, that succumb to disease.
Newly found gene variants account for kidney diseases among African-Americans
For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University.
Risk of fracture is significantly higher in HIV-infected patients
As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures.
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily challenging properties of the virus that have made a vaccine elusive and outline the scientific questions that, if answered, could lead to an effective HIV vaccine.
Study reveals gap in HIV testing knowledge among college students
Most college students understand how they can prevent the transmission of HIV but are less knowledgeable about HIV testing, according to a new University of Georgia study.
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well tolerated.
More Hiv Infection Current Events and Hiv Infection News Articles
| Cell Death During HIV Infection Although immune-based therapies have been the primary focus in the battle to arrest HIV, researchers now are considering the implications of apoptosis dysregulation during HIV-induced immunodeficiency. Mounting evidence indicates that cell death is not a passive process, but rather one that is tightly coordinated and regulated. This opens the door to the intriguing possibility that apoptotic cell... | |
| The The Johns Hopkins Hospital 2005-06 Guide to Medical Care of Patients with HIV Infection, Revised (Johns Hopkins Guide to the Medical Care of Patients with HIV) by John G Bartlett This manual is the definitive guide to the care of HIV-infected patients, written by Dr. John Bartlett, a world-renowned expert. The book reflects the most up-to-date policies and recommendations of the AIDS Care Program at Johns Hopkins Hospital and includes current treatment guidelines from the Department of Health and Human Services and the International AIDS Society. The manual presents... | |
 | The Guide to Living with HIV Infection: Developed at the Johns Hopkins AIDS Clinic (A Johns Hopkins Press Health Book) by John G. Bartlett, Ann K. Finkbeiner The Guide to Living with HIV Infection is the most complete source of medical, emotional, social, and practical advice available for those infected with HIV and their loved ones. Developed at the Johns Hopkins AIDS Clinic, the guide provides essential information for making decisions about treatment and testing in a world transformed by new research and pharmacotherapy.In this thoroughly updated... |
 | A Woman's Guide to Living with HIV Infection (A Johns Hopkins Press Health Book) by Rebecca A. Clark, Robert T., Jr. Maupin, Jill Hayes Written by three experts with extensive experience helping people with HIV/AIDS, A Woman's Guide to Living with HIV Infection is a medically informational, comprehensive, and deeply compassionate resource for women with HIV and their families and friends. While addressing the entire range of health and emotional issues faced by people with HIV, the authors cover topics of special interest to... |
 | AIDS and Other Manifestations of HIV Infection, Fourth Edition Extensively revised and updated, the new edition of AIDS and Other Manifestations of HIV Infection is an essential reference resource providing a comprehensive overview of the biological properties of this etiologic viral agent, its clinicopathological manifestations, the epidemiology of its infection, and present and future therapeutic options. New to this... |
| Medical Management Of HIV Infection 2007 by John G. Bartlett, Joel E., M.D. Gallant | |
 | Medical Management of HIV Infection by John Bartlett |
 | Positive Nutrition for HIV Infection & AIDS: A Medically Sound Take-Charge Plan to Maintain Weight and Improve Your Quality of Life by Stacey J. Bell, R. Armour Forse Use the power of Positive Nutrition to improve health and feel better at any stage of HIV infection or AIDS Written by two Harvard Medical School doctors, this breakthrough book will show you how to maintain weight and enjoy the highest quality of life possible by radically changing the way you think about food--without radically changing your lifestyle. By following the three Principles of... |
| 2005-2006 Medical Management of HIV Infection by John G. Bartlett, Joel E., M.D. Gallant | |
 | Healing HIV: How To Rebuild Your Immune System by Jon D., M.D. Kaiser, Jon D. Kaiser |
| © 2008 BrightSurf.com |